{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:00:50Z","timestamp":1781629250075,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":102,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82170910"],"award-info":[{"award-number":["No. 82170910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"2024-National Clinical Key Specialty Construction Project","award":["No.10000015Z155080000004"],"award-info":[{"award-number":["No.10000015Z155080000004"]}]},{"DOI":"10.13039\/501100015349","name":"Key Laboratory of Inorganic Functional Materials and Devices","doi-asserted-by":"publisher","award":["No. 24dz2260100"],"award-info":[{"award-number":["No. 24dz2260100"]}],"id":[{"id":"10.13039\/501100015349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["NO. 23J41900200"],"award-info":[{"award-number":["NO. 23J41900200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2703102"],"award-info":[{"award-number":["2022YFC2703102"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary mitochondrial disorders (MDs) are genetically and clinically heterogeneous metabolic diseases caused by mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) mutations. Pediatric MDs pose diagnostic challenges due to variable onset, multisystem involvement, and complex genotype\u2013phenotype correlations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 69 children with suspected MDs at Shanghai Children\u2019s Medical Center (2015\u20132025). Genetic diagnoses were established through targeted next-generation sequencing (NGS) combined with clinical, biochemical, and neuroimaging evaluation. Forty-seven patients were genetically confirmed and classified into mtDNA and nDNA groups for comparison.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The diagnostic yield was 68% (47\/69). mtDNA mutations accounted for 64% (30\/47), with\n                      <jats:italic>MT-TL1<\/jats:italic>\n                      m.3243\u00a0A\u2009&gt;\u2009G being the most frequent (60%), followed by\n                      <jats:italic>MT-ATP6<\/jats:italic>\n                      m.8993T\u2009&gt;\u2009C and\n                      <jats:italic>MT-ND6<\/jats:italic>\n                      m.14484T\u2009&gt;\u2009C. nDNA mutations (36%) affected 12 genes, mostly related to complex I. Common phenotypes included MELAS (45%) and Leigh syndrome (LS) (28%). Compared to nDNA cases, mtDNA patients had higher epilepsy (64.5% vs. 43.8%) and stroke-like episodes (58.1% vs. 31.2%), while nDNA cases had earlier onset (1.15 vs. 5.42 years,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and more hypoglycemia.\n                      <jats:italic>MT-TL1<\/jats:italic>\n                      pedigrees showed maternal inheritance, phenotypic variability, and generational worsening. Mutation load was higher in\n                      <jats:italic>MT-ATP6<\/jats:italic>\n                      -related LS than in\n                      <jats:italic>MT-TL1<\/jats:italic>\n                      -related MELAS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.008). Serial neuroimaging revealed syndrome-specific progression. All six fatal cases exhibited a \u201cneuroimaging\u2013metabolic\u2013cardiac\/respiratory failure\u201d triad.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Chinese pediatric MDs show marked genetic and phenotypic heterogeneity. Recognizing genotype\u2013phenotype patterns, longitudinal imaging, and critical risk triads may improve diagnosis, management, and patient selection for future trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04180-7","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:47:35Z","timestamp":1767844055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and genetic spectrum of pediatric mitochondrial disorders in China: insights from a 47-case genetically confirmed cohort"],"prefix":"10.1186","volume":"21","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiguo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2186-759X","authenticated-orcid":false,"given":"Xiumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"1","key":"4180_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","volume":"10","author":"H Wen","year":"2025","unstructured":"Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X, et al. Mitochondrial diseases: from molecular mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10(1):9.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4180_CR2","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/1873-3468.13995","volume":"595","author":"E Fernandez-Vizarra","year":"2021","unstructured":"Fernandez-Vizarra E, Zeviani M. Mitochondrial disorders of the OXPHOS system. FEBS Lett. 2021;595(8):1062\u2013106.","journal-title":"FEBS Lett"},{"issue":"1","key":"4180_CR3","first-page":"32","volume":"11","author":"BH Liu","year":"2024","unstructured":"Liu BH, Xu CZ, Liu Y, Lu ZL, Fu TL, Li GR, et al. Mitochondrial quality control in human health and disease. Mil Med Res. 2024;11(1):32.","journal-title":"Mil Med Res"},{"issue":"1","key":"4180_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13023-023-02632-6","volume":"18","author":"TS Wong","year":"2023","unstructured":"Wong TS, Belaramani KM, Chan CK, Chan WK, Chan WL, Chang SK, et al. Mitochondrial diseases in Hong kong: prevalence, clinical characteristics and genetic landscape. Orphanet J Rare Dis. 2023;18(1):43.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"4180_CR5","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/1471-0528.15667","volume":"126","author":"CL Feeney","year":"2019","unstructured":"Feeney CL, Lim AZ, Fagan E, Blain A, Bright A, Maddison J, et al. A case-comparison study of pregnant women with mitochondrial disease - what to expect? BJOG. 2019;126(11):1380\u20139.","journal-title":"BJOG"},{"issue":"4","key":"4180_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jimd.12521","volume":"45","author":"RH Thomas","year":"2022","unstructured":"Thomas RH, Hunter A, Butterworth L, Feeney C, Graves TD, Holmes S, et al. Research priorities for mitochondrial disorders: current landscape and patient and professional views. J Inherit Metab Dis. 2022;45(4):796\u2013803.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"4180_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s13311-013-0179-4","volume":"10","author":"O Hurko","year":"2013","unstructured":"Hurko O. Drug development for rare mitochondrial disorders. Neurotherapeutics. 2013;10(2):286\u2013306.","journal-title":"Neurotherapeutics"},{"key":"4180_CR8","doi-asserted-by":"publisher","first-page":"102784","DOI":"10.1016\/j.ebiom.2020.102784","volume":"56","author":"SL Stenton","year":"2020","unstructured":"Stenton SL, Prokisch H. Genetics of mitochondrial diseases: identifying mutations to help diagnosis. EBioMedicine. 2020;56:102784.","journal-title":"EBioMedicine"},{"issue":"3","key":"4180_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/acn3.52315","volume":"12","author":"Z Liu","year":"2025","unstructured":"Liu Z, Pan K, Wang M, Jin Y, Yang W, Chen K, et al. Novel pathogenic MtDNA variants in Chinese children with neurological mitochondrial disorders. Ann Clin Transl Neurol. 2025;12(3):586\u2013601.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"4180_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40246-020-00278-0","volume":"14","author":"MHY Tsang","year":"2020","unstructured":"Tsang MHY, Kwong AKY, Chan KLS, Fung JLF, Yu MHC, Mak CCY, et al. Delineation of molecular findings by whole-exome sequencing for suspected cases of paediatric-onset mitochondrial diseases in the Southern Chinese population. Hum Genomics. 2020;14(1):28.","journal-title":"Hum Genomics"},{"issue":"1","key":"4180_CR11","doi-asserted-by":"publisher","first-page":"e00325","DOI":"10.1016\/j.neurot.2024.e00325","volume":"21","author":"BJ Shayota","year":"2024","unstructured":"Shayota BJ. Biomarkers of mitochondrial disorders. Neurotherapeutics. 2024;21(1):e00325.","journal-title":"Neurotherapeutics"},{"issue":"10","key":"4180_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1212\/01.wnl.0000244435.27645.54","volume":"67","author":"E Morava","year":"2006","unstructured":"Morava E, van den Heuvel L, Hol F, de Vries MC, Hogeveen M, Rodenburg RJ, et al. Mitochondrial disease criteria: diagnostic applications in children. Neurology. 2006;67(10):1823\u20136.","journal-title":"Neurology"},{"key":"4180_CR13","doi-asserted-by":"crossref","unstructured":"Ryytty S, H\u00e4m\u00e4l\u00e4inen RH. The mitochondrial m.3243A\u2009>\u2009G mutation on the dish, lessons from in vitro models. Int J Mol Sci. 2023;24(17).","DOI":"10.3390\/ijms241713478"},{"issue":"2","key":"4180_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4158\/EP-2019-0270","volume":"26","author":"KN Robinson","year":"2020","unstructured":"Robinson KN, Terrazas S, Giordano-Mooga S, Xavier NA, THE ROLE OF HETEROPLASMY IN THE DIAGNOSIS AND MANAGEMENT OF MATERNALLY INHERITED DIABETES AND DEAFNESS. Endocr Pract. 2020;26(2):241\u20136.","journal-title":"Endocr Pract"},{"issue":"2","key":"4180_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2337\/db24-0515","volume":"74","author":"JP Chanoine","year":"2025","unstructured":"Chanoine JP, Thompson DM, Lehman A. Diabetes associated with maternally inherited diabetes and deafness (MIDD): from pathogenic variant to phenotype. Diabetes. 2025;74(2):153\u201363.","journal-title":"Diabetes"},{"issue":"4","key":"4180_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00247-025-06172-y","volume":"55","author":"SG Kandemirli","year":"2025","unstructured":"Kandemirli SG, Al-Dasuqi K, Aslan B, Goldstein A, Alves C. Overview of neuroimaging in primary mitochondrial disorders. Pediatr Radiol. 2025;55(4):765\u201391.","journal-title":"Pediatr Radiol"},{"key":"4180_CR17","doi-asserted-by":"publisher","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"GS Gorman","year":"2016","unstructured":"Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, et al. Mitochondrial diseases. Nat Rev Dis Primers. 2016;2:16080.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"4180_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/humu.23387","volume":"39","author":"AW El-Hattab","year":"2018","unstructured":"El-Hattab AW, Wang J, Dai H, Almannai M, Staufner C, Alfadhel M, et al. MPV17-related mitochondrial DNA maintenance defect: new cases and review of clinical, biochemical, and molecular aspects. Hum Mutat. 2018;39(4):461\u201370.","journal-title":"Hum Mutat"},{"issue":"7","key":"4180_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/iub.2018","volume":"71","author":"S Ghosh","year":"2019","unstructured":"Ghosh S, Iadarola DM, Ball WB, Gohil VM. Mitochondrial dysfunctions in Barth syndrome. IUBMB Life. 2019;71(7):791\u2013801.","journal-title":"IUBMB Life"},{"issue":"3","key":"4180_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ymgme.2009.10.003","volume":"99","author":"AW El-Hattab","year":"2010","unstructured":"El-Hattab AW, Li FY, Schmitt E, Zhang S, Craigen WJ, Wong LJ. MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations. Mol Genet Metab. 2010;99(3):300\u20138.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4180_CR21","doi-asserted-by":"publisher","first-page":"e00324","DOI":"10.1016\/j.neurot.2024.e00324","volume":"21","author":"C Alves","year":"2024","unstructured":"Alves C, Whitehead MT. Advancing the neuroimaging diagnosis and Understanding of mitochondrial disorders. Neurotherapeutics. 2024;21(1):e00324.","journal-title":"Neurotherapeutics"},{"issue":"5\u20136","key":"4180_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.mito.2008.05.003","volume":"8","author":"RP Saneto","year":"2008","unstructured":"Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion. 2008;8(5\u20136):396\u2013413.","journal-title":"Mitochondrion"},{"issue":"2","key":"4180_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s13311-012-0161-6","volume":"10","author":"AL Gropman","year":"2013","unstructured":"Gropman AL. Neuroimaging in mitochondrial disorders. Neurotherapeutics. 2013;10(2):273\u201385.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"4180_CR24","doi-asserted-by":"publisher","first-page":"e209779","DOI":"10.1212\/WNL.0000000000209779","volume":"104","author":"A Ivaniuk","year":"2025","unstructured":"Ivaniuk A, Anselm IA, Bowen A, Cohen BH, Eminoglu FT, Estrella J, et al. Characterization of factors associated with death in deceased patients with mitochondrial disorders: A multicenter Cross-Sectional survey. Neurology. 2025;104(4):e209779.","journal-title":"Neurology"},{"key":"4180_CR25","doi-asserted-by":"crossref","unstructured":"Parikh S, Goldstein A, Karaa A, Koenig MK, Anselm I, Brunel-Guitton C et al. Patient care standards for primary mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2017;19(12).","DOI":"10.1038\/gim.2017.107"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04180-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04180-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04180-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:17:28Z","timestamp":1781626648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04180-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4180"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04180-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional committee and the 2000 revision of the Helsinki Declaration. The protocol was approved by the Ethics Committee of Shanghai Children\u2019s Medical Center (SCMCIRB-K2020060-1), and informed consent for publication was obtained from all participating families.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the patient\u2019s parent of the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest related. The authors state that the material is original, has not been previously published, and has not been submitted for publication elsewhere while under consideration.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}